TREATMENT OF CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA WITH INTRAVITREAL BEVACIZUMAB
- 1 October 2006
- journal article
- case report
- Published by Wolters Kluwer Health in Retina
- Vol. 26 (8) , 960-963
- https://doi.org/10.1097/01.iae.0000240121.28034.c3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular DegenerationOphthalmology, 2006
- Laser photocoagulation for choroidal neovascularisation in pathologic myopiaCochrane Database of Systematic Reviews, 2005
- Bevacizumab suppresses choroidal neovascularisation caused by pathological myopiaBritish Journal of Ophthalmology, 2005
- Cataract Progression After Intravitreal Triamcinolone InjectionAmerican Journal of Ophthalmology, 2005
- Intravitreal triamcinolone acetonide and intraocular pressureAmerican Journal of Ophthalmology, 2004
- Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopiaOphthalmology, 2003
- Laser photocoagulation of choroidal neovascularization in pathologic myopia: long-term resultsInternational Ophthalmology, 1995
- PHOTOCOAGULATION SCAR EXPANSION AFTER LASER THERAPY FOR CHOROIDAL NEOVASCULARIZATION IN DEGENERATIVE MYOPIARetina, 1990